Treatment Technologies & Insights (TTI) is revolutionizing healthcare with its patient engagement and AI-driven insights. TTI develops patient-reported outcome apps and platforms (ePROs) to enhance health outcomes for chronic condition patients. Its flagship product, Wave Health, leverages Artificial Intelligence to provide personalized health insights derived from patients' unique chronic condition experiences, supporting self-management and remote monitoring. This ultimately helps in mitigating emerging risks, improving QoL, and treatment impact. Wave Health App has gained acclaim, being ranked as the #1 mHealth app for tracking patient reported outcomes in oncology, as per a systemic review by Cedars-Sinai Medical Center. TTI, headquartered in the United States, was founded in 2016 and recently secured a $1.50M Venture Round investment on 31 August 2022. With its innovative approach and accolades, TTI presents a promising investment opportunity in the health-tech industry. Visit TTI & Wave Health at https://tti.care/ and https://www.wavehealth.app/.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Venture Round | $1.50M | - | 31 Aug 2022 | |
Convertible Note | $1.58M | - | 21 Dec 2017 |
No recent news or press coverage available for Treatment Technologies & Insights.